Tuberculosis can be treated, prevented, and cured. Rapid, sustained declines in tuberculosis
deaths in many countries during the past 50 years provide compelling evidence that …

Background In the context of WHO's End TB strategy, there is a need to focus future control
efforts on those interventions and innovations that would be most effective in accelerating …

Background The incidence of multidrug-resistant tuberculosis (MDR-TB) remains critically
high in countries of the former Soviet Union, where >20% of new cases and >50% of …

Few studies have explored drug injectors’ accounts of their initiation of others into injecting.
There also lacks research on the social relations of initiating injecting drug use in transitional …

Whereas most research investigating drug use transitions narrows its analyses around the
individual and their decision-making, we explore how personal narratives of drug transition …

Introduction Several countries have set up youth-friendly-health-services. Relatively little is
known about approaches to systematically assess their performance against set standards in …

High rates of drug-resistant tuberculosis (DR-TB) continue to threaten public health, especially
in Eastern Europe. Costs for treating DR-TB are substantially higher than treating drug-…

Introduction Since 2013, the European Testing Week (ETW) awareness campaign has
become a key regional event influencing testing efforts for HIV, viral hepatitis, and sexually …

The BPaLM regimen (bedaquiline, pretomanid, linezolid and moxifloxacin) recently
recommended by the World Health Organization offers short, safe, and effective treatment for …

Following Russia’s invasion in 2022, over 4.1 million Ukrainians sought refuge in the EU/EEA.
We assessed how this impacted HIV case reporting by EU/EEA countries. Ukrainian …